COMMUNIQUÉS West-GlobeNewswire

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

19/10/2024 - 05:00

SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today [...]

Le KFSHRC impose son leadership en matière de veille dans les soins de santé pour le diagnostic et les soins aux patients

19/10/2024 - 13:16

RIYAD, Arabie Saoudite, 19 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) contribue à l’innovation mondiale en matière de soins de santé, en tirant parti de l’ [...]

Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia

19/10/2024 - 14:00

NX-5948 demonstrated robust clinical activity with objective responses observed in 7 of 9 (77.8%) evaluable Waldenstrom’s patients in the ongoing Phase 1a/1b clinical trial Responses are durable and deepen over time [...]

KFSHRC Pioneers Cancer Treatment with Breakthrough Therapies and Exceptional Outcomes

19/10/2024 - 14:14

RIYADH, Saudi Arabia, Oct. 19, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing cancer treatment in the region with transformative therapies like CAR-T cell [...]

Telix Files Form 20-F Registration Statement for Nasdaq ADS

17/10/2024 - 23:28

MELBOURNE, Australia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registration Statement) with [...]

Fortrea publie son premier rapport de Responsabilité Sociale d’Entreprise

18/10/2024 - 01:43

DURHAM, Caroline du Nord, 18 oct. 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE), l’un des principaux organismes internationaux de recherche sous contrat (CRO), a annoncé aujourd’hui la publication du premier rapport [...]

ITM and NTP Strengthen Global Radioisotope Production Capacities by Renewing their Technology License Agreement and Signing a Manufacturing and Supply Agreement for n.c.a. Lutetium-177

18/10/2024 - 11:00

Extension of 2012 agreement grants NTP the rights to manufacture and distribute non-carrier-added Lutetium-177 (n.c.a. 177 Lu) Companies enter into an additional manufacturing and supply agreement for NTP to produce and [...]

Novo Nordisk A/S: Alhemo® recommended for European approval as first once-daily subcutaneous prophylactic treatment for people living with haemophilia A or B with inhibitors

18/10/2024 - 11:32

Bagsværd, Denmark, 18 October 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending approval of [...]

Nxera Pharma to Host R&D Day 2024

18/10/2024 - 11:38

Nxera Pharma Co., Ltd. will hold an R&D Day on 6 November 2024 at 16:30 JST. The meeting will be held virtually via Zoom webinar. Please click here to pre-register for the event. Date : Wednesday, 6 November 2024 [...]

Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition

18/10/2024 - 12:00

Combined company will emerge as a leading global health and wellness company by providing better products and solutions for pets, people, and families Combined 2025 revenue and EBITDA expected to be approximately +$270 [...]

Le KFSHRC présente ses dernières innovations et solutions de santé à l’occasion de la Global Health Exhibition 2024

18/10/2024 - 12:15

RIYAD, Arabie saoudite, 18 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSHRC) participera comme principal sponsor (Platine) à l’édition 2024 du Forum mondial de la santé ( [...]

Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer

18/10/2024 - 12:47

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment with Kisqali ® ( [...]

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

18/10/2024 - 12:50

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, British Columbia, Oct. 18, [...]

KFSHRC Leads Healthcare Intelligence in Diagnostics and Patient Care

18/10/2024 - 12:52

RIYADH, Saudi Arabia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is contributing to global healthcare innovation, leveraging artificial intelligence (AI) and [...]

ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer

18/10/2024 - 13:00

ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer Cambridge UK , 18 October 2024 – ViaNautis Bio (“ViaNautis” or the “Company”), a groundbreaking nanomedicine company at the forefront of genetic therapies, [...]

Phase III trial results of novel triple combination pill for hypertension published in The Lancet

18/10/2024 - 13:00

Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill significantly reduced blood pressure and improved control rates vs dual therapy, with good [...]

UPDATE -- Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition

18/10/2024 - 13:49

Combined company will emerge as a leading global health and wellness company by providing better products and solutions for pets, people, and families Combined 2025 revenue and EBITDA expected to be approximately +$270 [...]

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

18/10/2024 - 14:00

NEWTOWN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for [...]

Alignment Healthcare to Announce Third Quarter 2024 Financial Results and Host Conference Call Tuesday, Oct. 29, 2024

18/10/2024 - 14:00

ORANGE, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2024 financial results on Tuesday, Oct. 29, 2024, after market close. Following the release, [...]